Mallinckrodt shares drop after U.S. joins cases over expensive drug

The U.S. Justice Department has joined a pair of whistleblower lawsuits alleging a drugmaker now owned by Mallinckrodt Plc improperly promoted an expensive multiple sclerosis treatment and paid kickbacks to doctors who prescribed the drug.

from Reuters: Health News https://reut.rs/2ZLKonL
http://bit.ly/xePdMM